Published in Blood on September 14, 2006
Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell (2009) 11.26
Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol (2009) 3.17
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nat Rev Cancer (2009) 3.06
Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J (2008) 2.53
Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol (2012) 2.48
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog (2009) 2.24
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. J Clin Invest (2008) 1.74
A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood (2008) 1.69
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses. J Virol (2007) 1.50
Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem (2009) 1.35
Innate immune sensing of DNA viruses. Virology (2011) 1.30
Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS One (2010) 1.28
Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components. J Virol (2008) 1.26
The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus. J Immunol (2009) 1.24
Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA. Proc Natl Acad Sci U S A (2010) 1.24
Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog (2010) 1.22
Innate immune recognition of viruses and viral vectors. Hum Gene Ther (2009) 1.22
Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases. Proc Natl Acad Sci U S A (2013) 1.17
Toll-like receptor agonists: are they good adjuvants? Cancer J (2010) 1.16
A virological view of innate immune recognition. Annu Rev Microbiol (2012) 1.14
NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells. J Immunol (2012) 1.11
Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity. Clin Exp Immunol (2007) 1.09
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models. J Virol (2009) 1.06
Recent insights into the role of Toll-like receptors in viral infection. Clin Exp Immunol (2010) 1.06
Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol J (2008) 1.04
Differential innate immune signaling in macrophages by wild type vaccinia mature virus and a mutant virus deleting A26 protein. J Virol (2017) 1.03
Toll-like receptors in antiviral innate immunity. J Mol Biol (2013) 1.03
Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog (2008) 1.02
Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection. J Virol (2010) 0.98
Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production. Glia (2009) 0.97
Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses. Cell Host Microbe (2010) 0.97
Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines. Viruses (2013) 0.95
Type I interferons: diversity of sources, production pathways and effects on immune responses. Curr Opin Virol (2011) 0.95
Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis. Jundishapur J Microbiol (2014) 0.95
Developments in Viral Vector-Based Vaccines. Vaccines (Basel) (2014) 0.94
dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunol Rev (2011) 0.93
Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection. PLoS One (2010) 0.93
TRAM is required for TLR2 endosomal signaling to type I IFN induction. J Immunol (2014) 0.91
Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes. J Leukoc Biol (2013) 0.91
Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovis. J Virol (2009) 0.90
Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A. PLoS One (2013) 0.89
A novel TLR3 inhibitor encoded by African swine fever virus (ASFV). Arch Virol (2011) 0.89
The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors. Vaccine (2014) 0.88
High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination. J Infect Dis (2012) 0.88
Suppression of TLR9 immunostimulatory motifs in the genome of a gammaherpesvirus. J Immunol (2011) 0.88
Interplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells. J Virol (2011) 0.88
CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells. J Immunol (2014) 0.87
Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver. PLoS One (2012) 0.87
Regulation of maturation and activating potential in CD8+ versus CD8- dendritic cells following in vivo infection with vaccinia virus. Virology (2008) 0.85
Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development. Clin Exp Immunol (2009) 0.85
Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection. J Virol (2015) 0.84
Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice. J Immunol (2009) 0.84
The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation. J Immunol (2009) 0.83
Virotherapy, gene transfer and immunostimulatory monoclonal antibodies. Oncoimmunology (2012) 0.83
Both NK cell-intrinsic and -extrinsic STAT1 signaling are required for NK cell response against vaccinia virus. J Immunol (2013) 0.82
Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses. J Immunol (2012) 0.82
Role of type I interferon receptor signaling on NK cell development and functions. PLoS One (2014) 0.81
Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu. J Virol (2014) 0.81
Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection. Virology (2011) 0.81
CD8 marks a subpopulation of lung-derived dendritic cells with differential responsiveness to viral infection and toll-like receptor stimulation. J Virol (2012) 0.81
A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity. PLoS One (2012) 0.80
Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus. Front Immunol (2013) 0.80
Impact of infection or vaccination on pre-existing serological memory. Hum Immunol (2012) 0.80
NK cell-extrinsic IL-18 signaling is required for efficient NK-cell activation by vaccinia virus. Eur J Immunol (2014) 0.79
TLR2 joins the interferon gang. Nat Immunol (2009) 0.79
Novel drugs targeting Toll-like receptors for antiviral therapy. Future Virol (2014) 0.79
Type I interferons mediate the innate cytokine response to recombinant fowlpox virus but not the induction of plasmacytoid dendritic cell-dependent adaptive immunity. J Virol (2010) 0.79
Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines. Hum Vaccin Immunother (2012) 0.79
Vaccinia virus, a promising new therapeutic agent for pancreatic cancer. Immunotherapy (2015) 0.78
Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2. J Virol (2013) 0.77
MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2. J Virol (2014) 0.76
Herpesviral infection and Toll-like receptor 2. Protein Cell (2012) 0.76
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics. J Immunother Cancer (2015) 0.75
Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination. J Neuroinflammation (2016) 0.75
Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection. Front Immunol (2016) 0.75
The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594). Oncolytic Virother (2015) 0.75
IL-18-dependent NKG2D ligand upregulation on accessory cells is mediated by the PI3K/GSK-3 pathway. J Leukoc Biol (2017) 0.75
Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus. Eur J Immunol (2017) 0.75
Skin microbiome and mast cells. Transl Res (2017) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature (2001) 25.15
The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell (2002) 20.11
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol (2005) 18.32
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 17.57
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 17.40
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 16.26
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science (2004) 14.80
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science (2003) 14.04
Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity (2006) 10.61
Plasmacytoid dendritic cells in immunity. Nat Immunol (2004) 9.11
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 9.09
Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity (1998) 9.02
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol (2005) 7.94
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med (2003) 7.26
Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science (1996) 7.00
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med (2005) 6.59
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol (2003) 5.36
CD14 is required for MyD88-independent LPS signaling. Nat Immunol (2005) 5.20
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci U S A (1983) 4.69
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature (2003) 4.60
Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol (2003) 4.15
NLRs join TLRs as innate sensors of pathogens. Trends Immunol (2005) 4.12
Type I interferons keep activated T cells alive. J Exp Med (1999) 3.98
Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol (2002) 3.91
Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol (2002) 3.37
Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci U S A (2003) 3.29
Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science (2002) 3.05
Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol (2004) 3.00
Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med (1999) 2.98
Toll-dependent control mechanisms of CD4 T cell activation. Immunity (2004) 2.88
Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol (2004) 2.84
Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci U S A (2004) 2.79
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci U S A (2005) 2.57
Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med (2002) 2.47
Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol (1996) 1.58
Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model. Vaccine (1997) 1.32
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr). Cancer Immunol Immunother (2004) 1.03
Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC. Dev Biol Stand (1995) 0.96
Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol (2004) 3.00
Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab (2012) 2.48
Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol (2007) 2.33
Does DSM-IV already capture the dimensional nature of personality disorders? J Clin Psychiatry (2011) 2.06
Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity (2013) 1.83
Noncanonical autophagy promotes the visual cycle. Cell (2013) 1.74
The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest (2009) 1.73
Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. Blood (2012) 1.71
A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood (2008) 1.69
The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci (2006) 1.51
CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses. J Immunol (2007) 1.50
Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nat Immunol (2013) 1.47
Metabolic communication between astrocytes and neurons via bicarbonate-responsive soluble adenylyl cyclase. Neuron (2012) 1.36
Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection. J Immunol (2011) 1.26
Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J Immunol (2008) 1.26
Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA. Proc Natl Acad Sci U S A (2010) 1.24
Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog (2010) 1.22
Innate immune recognition of viruses and viral vectors. Hum Gene Ther (2009) 1.22
Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus. J Immunol (2007) 1.20
A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Mol Ther (2008) 1.15
STAT1 signaling in CD8 T cells is required for their clonal expansion and memory formation following viral infection in vivo. J Immunol (2008) 1.12
NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells. J Immunol (2012) 1.11
Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell Signal (2004) 1.08
Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest (2015) 1.04
Natural killer cell responses to viral infection. J Innate Immun (2011) 1.03
Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2010) 1.03
N-methyldihydroquinazolinone derivatives of Retro-2 with enhanced efficacy against Shiga toxin. J Med Chem (2013) 1.00
Transient gain of effector function by CD8+ T cells undergoing peripheral tolerance to high-dose self-antigen. Eur J Immunol (2004) 0.95
Extent of stimulation controls the formation of memory CD8 T cells. J Immunol (2007) 0.91
Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer. J Virol (2012) 0.90
Neuronal expression of soluble adenylyl cyclase in the mammalian brain. Brain Res (2013) 0.89
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors. Cancer Invest (2011) 0.89
Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta. J Immunol (2005) 0.88
Why do some depressed outpatients who are not in remission according to the hamilton depression rating scale nonetheless consider themselves to be in remission? Depress Anxiety (2012) 0.88
Development of a 4-nitroquinoline-1-oxide model of lymph node metastasis in oral squamous cell carcinoma. Oral Oncol (2012) 0.86
The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation. Immunology (2006) 0.86
Further evidence that the cutoff to define remission on the 17-item Hamilton Depression Rating Scale should be lowered. Depress Anxiety (2011) 0.85
Interaction of occupational manganese exposure and alcohol drinking aggravates the increase of liver enzyme concentrations from a cross-sectional study in China. Environ Health (2013) 0.84
Does the presence of one feature of borderline personality disorder have clinical significance? Implications for dimensional ratings of personality disorders. J Clin Psychiatry (2011) 0.84
NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus. J Immunol (2010) 0.84
The role of natural regulatory T cells in infection. Immunol Res (2011) 0.84
The development and function of memory regulatory T cells after acute viral infections. J Immunol (2012) 0.83
Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses. Expert Opin Ther Targets (2010) 0.83
Both NK cell-intrinsic and -extrinsic STAT1 signaling are required for NK cell response against vaccinia virus. J Immunol (2013) 0.82
Determination of beta2-agonists by ion chromatography with direct conductivity detection. J Pharm Biomed Anal (2005) 0.81
In silico syndrome prediction for coronary artery disease in traditional chinese medicine. Evid Based Complement Alternat Med (2012) 0.81
Is dimensional scoring of borderline personality disorder important only for subthreshold levels of severity? J Pers Disord (2013) 0.81
Cognitive function and plasma BDNF levels among manganese-exposed smelters. Occup Environ Med (2014) 0.81
Enantiomeric separation of beta-blockers by HPLC using (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid as chiral stationary phase. J Pharm Biomed Anal (2003) 0.80
Targeting co-stimulatory pathways in gene therapy. Front Microbiol (2011) 0.80
Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation. Blood (2009) 0.80
Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula. Mol Biosyst (2013) 0.79
Immunotherapy of surgical malignancies. Curr Probl Surg (2004) 0.79
NK cell-extrinsic IL-18 signaling is required for efficient NK-cell activation by vaccinia virus. Eur J Immunol (2014) 0.79
Anxiety symptoms among remitted depressed outpatients: prevalence and association with quality of life and psychosocial functioning. J Affect Disord (2013) 0.79
Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission. J Affect Disord (2012) 0.78
How should residual symptoms be defined in depressed patients who have remitted? Compr Psychiatry (2012) 0.78
Comorbid bipolar disorder and borderline personality disorder and history of suicide attempts. J Pers Disord (2013) 0.78
Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation. J Clin Invest (2015) 0.77
The benefits of restraint: a pivotal role for IL-13 in hepatic glucose homeostasis. J Clin Invest (2012) 0.77
An empirical examination of Gunderson's proposed revision of the diagnostic algorithm for borderline personality disorder. J Pers Disord (2012) 0.77
Which DSM-IV personality disorders are most strongly associated with indices of psychosocial morbidity in psychiatric outpatients? Compr Psychiatry (2012) 0.77
Corrigendum: Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells. Nature (2016) 0.76
Enhanced separation of purine and pyrimidine bases using carboxylic multiwalled carbon nanotubes as additive in capillary zone electrophoresis. Electrophoresis (2006) 0.76
On the use of dispersed nanoparticles modified with single layer beta-cyclodextrin as chiral selecor to enhance enantioseparation of clenbuterol with capillary electrophoresis. Talanta (2005) 0.75
Driving an improved CAR for cancer immunotherapy. J Clin Invest (2016) 0.75
[Prediction of network drug target based on improved model of bipartite graph valuation]. Zhongguo Zhong Yao Za Zhi (2012) 0.75
Scientists contemplate unexplained death in Austrian Alps. EMBO Mol Med (2011) 0.75
Chiral separation of four fluoroquinolone compounds using capillary electrophoresis with hydroxypropyl-beta-cyclodextrin as chiral selector. J Chromatogr A (2006) 0.75
PD-L1 serves as a double agent in separating GVL from GVHD. J Clin Invest (2017) 0.75
A clinically useful social anxiety disorder outcome scale. Compr Psychiatry (2013) 0.75
Psychiatric disorder-weight associations and the moderating effect of sex in an outpatient psychiatric sample. Ann Clin Psychiatry (2015) 0.75
[Study on chemical constituents from stem of Mallotus apelta]. Zhong Yao Cai (2005) 0.75
SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12. Vaccine (2013) 0.75
Impact of deleting 5 DSM-IV personality disorders on prevalence, comorbidity, and the association between personality disorder pathology and psychosocial morbidity. J Clin Psychiatry (2012) 0.75
Capillary electrophoretic determination of apoptosis of rat cerebellar granule cells induced by 1-methyl-4-phenyl pyridium ion. Electrophoresis (2002) 0.75